SUMATRIPTAN SUCCINA
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F9650 to DMS Pharmaceutical Group Inc on September 8, 2026, for a total price of 5,770.82 dollars. This award is a delivery order placed under the base administrative contract SPE2DX25D9900 and is specifically for the procurement of Sumatriptan Succinate, identified by national stock number 6505017275845 and purchase request 7018235775. The order was issued by the DLA Troop Support Medical Supply Chain and requires the delivery of the supplies to Fort Lewis, Washington, by September 23, 2026. This transaction is part of a broader procurement framework where the base contract SPE2DX25D9900, effective April 2, 2025, replaced previous administrative agreements to streamline the acquisition of commercial medical items.
General Info
Contract Value
$5,770.82Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
